跳至主要内容
临床试验/NCT01749826
NCT01749826终止不适用

Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

Stanford University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
20
试验地点
1
主要终点
Changes in Cytokine Release

研究概览

简要总结

We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.

详细描述

We are interested in learning how the immune system and the inflammation process is effected by acute and chronic opioid exposure. Preliminary evidence in animal models show that acute opioid exposure leads to decreased inflammatory responses, while chronic opioid exposure causes increased inflammatory responses, as measured by local cytokine release at the site of injury. Translating these findings to humans will lead to important new mechanistic knowledge that may ultimately improve our ability to treat pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-60 years old
  • Healthy volunteer
  • Not allergic to remifentanil

排除标准

  • Patients younger than 18 or older than 70
  • Patients unwilling or unable to follow study instructions
  • Patients who don't speak English
  • Patients who are taking prescription opioid medications (e.g. vicodin, percocet) or are unwilling to refrain from taking anti-inflammatory medications such as Advil or Naproxen during 2 weeks prior to and during the 1 month study

研究组 & 干预措施

Chronic Opioid Exposure

Experimental

15mg sustained release morphine sulfate, with a maximum dose of 120mg. Patients will be titrated up to a maximum dose of 8 pills a day for one month.

干预措施: Morphine Sulfate (Drug)

Acute Opioid Exposure

Experimental

15mg sustained release morphine sulfate, with a maximum dose of 120mg. Patients will be titrated up to a maximum dose of 8 pills a day for one month.

干预措施: Morphine Sulfate (Drug)

结局指标

主要结局

Changes in Cytokine Release

时间窗: Changes in cytokine release are compared between blood samples drawn on Day 1 and Day 30

5 CCs of blood are drawn on day 1 and day 30.

次要结局

  • Peltier Device-Heat Pain(Differences in heat pain are assessed between measurements taken on Day 1 and Day 30)
  • Mechanical Pain Stimuli(Changes in mechanical pain stimuli will be assessed between measurements taken on Day 1 and Day 30)
  • Laser Doppler Images(Changes in laser doppler images are measured between images taken on Day 1 and Day 30)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Larry Fu-nien Chu

Associate Professor of Anesthesia

Stanford University

研究点 (1)

Loading locations...

相似试验